<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34291734</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>14</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>22</Day></PubDate></JournalIssue><Title>JCI insight</Title><ISOAbbreviation>JCI Insight</ISOAbbreviation></Journal><ArticleTitle>Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e148363</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.148363</ELocationID><Abstract><AbstractText>Mutations in HNRNPA1 encoding heterogeneous nuclear ribonucleoprotein (hnRNP) A1 are a rare cause of amyotrophic lateral sclerosis (ALS) and multisystem proteinopathy (MSP). hnRNPA1 is part of the group of RNA-binding proteins (RBPs) that assemble with RNA to form RNPs. hnRNPs are concentrated in the nucleus and function in pre-mRNA splicing, mRNA stability, and the regulation of transcription and translation. During stress, hnRNPs, mRNA, and other RBPs condense in the cytoplasm to form stress granules (SGs). SGs are implicated in the pathogenesis of (neuro-)degenerative diseases, including ALS and inclusion body myopathy (IBM). Mutations in RBPs that affect SG biology, including FUS, TDP-43, hnRNPA1, hnRNPA2B1, and TIA1, underlie ALS, IBM, and other neurodegenerative diseases. Here, we characterize 4 potentially novel HNRNPA1 mutations (yielding 3 protein variants: *321Eext*6, *321Qext*6, and G304Nfs*3) and 2 known HNRNPA1 mutations (P288A and D262V), previously connected to ALS and MSP, in a broad spectrum of patients with hereditary motor neuropathy, ALS, and myopathy. We establish that the mutations can have different effects on hnRNPA1 fibrillization, liquid-liquid phase separation, and SG dynamics. P288A accelerated fibrillization and decelerated SG disassembly, whereas *321Eext*6 had no effect on fibrillization but decelerated SG disassembly. By contrast, G304Nfs*3 decelerated fibrillization and impaired liquid phase separation. Our findings suggest different underlying pathomechanisms for HNRNPA1 mutations with a possible link to clinical phenotypes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beijer</LastName><ForeName>Danique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Translational Neurosciences, Faculty of Medicine and Health Sciences, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hong Joo</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donovan</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mademan</LastName><ForeName>In&#xe8;s</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Translational Neurosciences, Faculty of Medicine and Health Sciences, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deconinck</LastName><ForeName>Tine</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Schil</LastName><ForeName>Kristof</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fare</LastName><ForeName>Charlotte M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drake</LastName><ForeName>Lauren E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Alice F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kocha&#x144;ski</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuromuscular Unit, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabzi&#x144;ska</LastName><ForeName>Dagmara</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neuromuscular Unit, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubuisson</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Neuromuscular Reference Centre, University Hospitals St-Luc, University of Louvain, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van den Bergh</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Neuromuscular Reference Centre, University Hospitals St-Luc, University of Louvain, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voermans</LastName><ForeName>Nicol C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemmers</LastName><ForeName>Richard Jlf</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Human Genetics Department, Leiden University Medical Center, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Maarel</LastName><ForeName>Silv&#xe8;re M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Human Genetics Department, Leiden University Medical Center, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonner</LastName><ForeName>Devon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Stanford Center for Undiagnosed Diseases, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sampson</LastName><ForeName>Jacinda B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Stanford Center for Undiagnosed Diseases, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wheeler</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Stanford Center for Undiagnosed Diseases, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehrabyan</LastName><ForeName>Anahit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmer</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Jonghe</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Translational Neurosciences, Faculty of Medicine and Health Sciences, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Wilrijk, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuromuscular Reference Centre, Department of Neurology, Antwerp University Hospital, Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorter</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>J Paul</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baets</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Translational Neurosciences, Faculty of Medicine and Health Sciences, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Wilrijk, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuromuscular Reference Centre, Department of Neurology, Antwerp University Hospital, Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F31 NS111870</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG000255</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 NS069539</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG007708</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 NS097974</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM099836</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM008275</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM138109</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 NS087676</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCI Insight</MedlineTA><NlmUniqueID>101676073</NlmUniqueID><ISSNLinking>2379-3708</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076245">Heterogeneous Nuclear Ribonucleoprotein A1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619656">hnRNPA1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076245" MajorTopicYN="N">Heterogeneous Nuclear Ribonucleoprotein A1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="N">Muscular Atrophy, Spinal</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088162" MajorTopicYN="N">Stress Granules</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073359" MajorTopicYN="N">Exome Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cell stress</Keyword><Keyword MajorTopicYN="N">Genetics</Keyword><Keyword MajorTopicYN="N">Neurological disorders</Keyword><Keyword MajorTopicYN="N">Neuroscience</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> JS is a consultant for Dewpoint Therapeutics, Maze Therapeutics, Vivid Sciences, Korro Bio, and ADRx.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>22</Day><Hour>8</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34291734</ArticleId><ArticleId IdType="pmc">PMC8410042</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.148363</ArticleId><ArticleId IdType="pii">e148363</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Park SJ, et al. Heterogeneous nuclear ribonucleoprotein A1 post-transcriptionally regulates Drp1 expression in neuroblastoma cells. Biochim Biophys Acta. 2015;1849(12):1423&#x2013;1431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4655839</ArticleId><ArticleId IdType="pubmed">26518267</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohagheghi F, et al. TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor. Hum Mol Genet. 2016;25(3):534&#x2013;545. doi: 10.1093/hmg/ddv491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv491</ArticleId><ArticleId IdType="pmc">PMC4731020</ArticleId><ArticleId IdType="pubmed">26614389</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao TT, et al. hnRNP A1 regulates UV-induced NF-kappaB signalling through destabilization of cIAP1 mRNA. Cell Death Differ. 2009;16(2):244&#x2013;252. doi: 10.1038/cdd.2008.146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2008.146</ArticleId><ArticleId IdType="pubmed">18846111</ArticleId></ArticleIdList></Reference><Reference><Citation>Guil S, Caceres JF. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol. 2007;14(7):591&#x2013;596. doi: 10.1038/nsmb1250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1250</ArticleId><ArticleId IdType="pubmed">17558416</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn RL, et al. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature. 2011;471(7339):532&#x2013;536. doi: 10.1038/nature09772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09772</ArticleId><ArticleId IdType="pmc">PMC3078637</ArticleId><ArticleId IdType="pubmed">21399625</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemieux B, et al. A function for the hnRNP A1/A2 proteins in transcription elongation. PLoS One. 2015;10(5):e0126654. doi: 10.1371/journal.pone.0126654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0126654</ArticleId><ArticleId IdType="pmc">PMC4444011</ArticleId><ArticleId IdType="pubmed">26011126</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau JS, et al. Heterogeneous nuclear ribonucleoproteins as regulators of gene expression through interactions with the human thymidine kinase promoter. J Cell Biochem. 2000;79(3):395&#x2013;406. doi: 10.1002/1097-4644(20001201)79:3&lt;395::AID-JCB50&gt;3.0.CO;2-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-4644(20001201)79:3&lt;395::AID-JCB50&gt;3.0.CO;2-M</ArticleId><ArticleId IdType="pubmed">10972977</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AF, Shorter J. RNA-binding proteins with prion-like domains in health and disease. Biochem J. 2017;474(8):1417&#x2013;1438. doi: 10.1042/BCJ20160499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20160499</ArticleId><ArticleId IdType="pmc">PMC5639257</ArticleId><ArticleId IdType="pubmed">28389532</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky NB, Taylor JP. Bridging biophysics and neurology: aberrant phase transitions in neurodegenerative disease. Nat Rev Neurol. 2019;15(5):272&#x2013;286. doi: 10.1038/s41582-019-0157-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0157-5</ArticleId><ArticleId IdType="pubmed">30890779</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495(7442):467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, et al. Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology. 2013;80(20):1874&#x2013;1880. doi: 10.1212/WNL.0b013e3182929fc3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182929fc3</ArticleId><ArticleId IdType="pmc">PMC3908355</ArticleId><ArticleId IdType="pubmed">23635965</ArticleId></ArticleIdList></Reference><Reference><Citation>Keogh MJ, et al. Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource. Genome Res. 2017;27(1):165&#x2013;173. doi: 10.1101/gr.210609.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.210609.116</ArticleId><ArticleId IdType="pmc">PMC5204341</ArticleId><ArticleId IdType="pubmed">28003435</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, et al. Whole-exome sequencing identifies a missense mutation in hnRNPA1 in a family with flail arm ALS. Neurology. 2016;87(17):1763&#x2013;1769. doi: 10.1212/WNL.0000000000003256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003256</ArticleId><ArticleId IdType="pubmed">27694260</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H, et al. Molecular epidemiological study of familial amyotrophic lateral sclerosis in Japanese population by whole-exome sequencing and identification of novel HNRNPA1 mutation. Neurobiol Aging. 2018;61:255.e9&#x2013;255.e16. doi: 10.1016/j.neurobiolaging.2017.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.08.030</ArticleId><ArticleId IdType="pubmed">29033165</ArticleId></ArticleIdList></Reference><Reference><Citation>Calini D, et al. Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2013;34(11):2695.e11&#x2013;2695.e12. doi: 10.1016/j.neurobiolaging.2013.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.05.025</ArticleId><ArticleId IdType="pmc">PMC6591723</ArticleId><ArticleId IdType="pubmed">23827524</ArticleId></ArticleIdList></Reference><Reference><Citation>Soong BW, et al. Extensive molecular genetic survey of Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35(10):2423.e1&#x2013;2423.e6. doi: 10.1016/j.neurobiolaging.2014.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.05.008</ArticleId><ArticleId IdType="pubmed">24908169</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I, et al. hnRNPA2B1 and hnRNPA1 mutations are rare in patients with &#x201c;multisystem proteinopathy&#x201d; and frontotemporal lobar degeneration phenotypes. Neurobiol Aging. 2014;35(4):934.e5&#x2013;6. doi: 10.1016/j.neurobiolaging.2013.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.09.016</ArticleId><ArticleId IdType="pubmed">24119545</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelen M, et al. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy. Neurobiol Aging. 2014;35(8):1956.e9&#x2013;1956.e11. doi: 10.1016/j.neurobiolaging.2014.01.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.152</ArticleId><ArticleId IdType="pubmed">24612671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierdaszuk B, et al. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients. Folia Neuropathol. 2015;53(4):355&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">26785370</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentmann E, et al. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. FEBS J. 2013;280(18):4348&#x2013;4370. doi: 10.1111/febs.12287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12287</ArticleId><ArticleId IdType="pubmed">23587065</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet. 2010;19(21):4160&#x2013;4175. doi: 10.1093/hmg/ddq335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq335</ArticleId><ArticleId IdType="pmc">PMC2981014</ArticleId><ArticleId IdType="pubmed">20699327</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzikowski AR, et al. Stress-induced mRNP granules: form and function of processing bodies and stress granules. Wiley Interdiscip Rev RNA. 2019;10(3):e1524. doi: 10.1002/wrna.1524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1524</ArticleId><ArticleId IdType="pmc">PMC6500494</ArticleId><ArticleId IdType="pubmed">30793528</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YR, et al. Stress granules as crucibles of ALS pathogenesis. J Cell Biol. 2013;201(3):361&#x2013;372. doi: 10.1083/jcb.201302044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, et al. TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron. 2017;95(4):808&#x2013;816. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163(1):123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, et al. Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology. Elife. 2019;8:e39578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6426440</ArticleId><ArticleId IdType="pubmed">30893049</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. In vivo stress granule misprocessing evidenced in a FUS knock-in ALS mouse model. Brain. 2020;143(5):1350&#x2013;1367. doi: 10.1093/brain/awaa076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa076</ArticleId><ArticleId IdType="pubmed">32358598</ArticleId></ArticleIdList></Reference><Reference><Citation>Namkoong S, et al. Systematic characterization of stress-induced RNA granulation. Mol Cell. 2018;70(1):175&#x2013;187. doi: 10.1016/j.molcel.2018.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.02.025</ArticleId><ArticleId IdType="pmc">PMC6359928</ArticleId><ArticleId IdType="pubmed">29576526</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong A, et al. The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. Mol Cell. 2017;68(4):808&#x2013;820. doi: 10.1016/j.molcel.2017.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.10.015</ArticleId><ArticleId IdType="pmc">PMC5728175</ArticleId><ArticleId IdType="pubmed">29129640</ArticleId></ArticleIdList></Reference><Reference><Citation>Markmiller S, et al. Context-dependent and disease-specific diversity in protein interactions within stress granules. Cell. 2018;172(3):590&#x2013;604. doi: 10.1016/j.cell.2017.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.032</ArticleId><ArticleId IdType="pmc">PMC5969999</ArticleId><ArticleId IdType="pubmed">29373831</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler JR, et al. Distinct stages in stress granule assembly and disassembly. Elife. 2016;5:e18413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014549</ArticleId><ArticleId IdType="pubmed">27602576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha NL, et al. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol. 1999;147(7):1431&#x2013;1442. doi: 10.1083/jcb.147.7.1431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.147.7.1431</ArticleId><ArticleId IdType="pmc">PMC2174242</ArticleId><ArticleId IdType="pubmed">10613902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswami M, et al. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell. 2013;154(4):727&#x2013;736. doi: 10.1016/j.cell.2013.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.07.038</ArticleId><ArticleId IdType="pmc">PMC3811119</ArticleId><ArticleId IdType="pubmed">23953108</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackman P, et al. Welander distal myopathy is caused by a mutation in the RNA-binding protein TIA1. Ann Neurol. 2013;73(4):500&#x2013;509. doi: 10.1002/ana.23831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23831</ArticleId><ArticleId IdType="pubmed">23401021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323(5918):1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323(5918):1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci. 2014;17(5):664&#x2013;666. doi: 10.1038/nn.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3688</ArticleId><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A, et al. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol. 2011;70(6):913&#x2013;919. doi: 10.1002/ana.22534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pubmed">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C, et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology. 2004;63(4):724&#x2013;726. doi: 10.1212/01.WNL.0000134608.83927.B1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000134608.83927.B1</ArticleId><ArticleId IdType="pubmed">15326253</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YZ, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4) Am J Hum Genet. 2004;74(6):1128&#x2013;1135. doi: 10.1086/421054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421054</ArticleId><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Geuens T, et al. The hnRNP family: insights into their role in health and disease. Hum Genet. 2016;135(8):851&#x2013;867. doi: 10.1007/s00439-016-1683-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-016-1683-5</ArticleId><ArticleId IdType="pmc">PMC4947485</ArticleId><ArticleId IdType="pubmed">27215579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilpin KM, et al. ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1. Hum Mol Genet. 2015;24(9):2565&#x2013;2577. doi: 10.1093/hmg/ddv020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv020</ArticleId><ArticleId IdType="pubmed">25616961</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumi R, et al. Isolated inclusion body myopathy caused by a multisystem proteinopathy-linked hnRNPA1 mutation. Neurol Genet. 2015;1(3):e23. doi: 10.1212/NXG.0000000000000023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000023</ArticleId><ArticleId IdType="pmc">PMC4809462</ArticleId><ArticleId IdType="pubmed">27066560</ArticleId></ArticleIdList></Reference><Reference><Citation>Suel KE, et al. Modular organization and combinatorial energetics of proline-tyrosine nuclear localization signals. PLoS Biol. 2008;6(6):e137. doi: 10.1371/journal.pbio.0060137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0060137</ArticleId><ArticleId IdType="pmc">PMC2408616</ArticleId><ArticleId IdType="pubmed">18532879</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael WM, et al. Signal sequences that target nuclear import and nuclear export of pre-mRNA-binding proteins. Cold Spring Harb Symp Quant Biol. 1995;60:663&#x2013;668. doi: 10.1101/SQB.1995.060.01.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/SQB.1995.060.01.071</ArticleId><ArticleId IdType="pubmed">8824440</ArticleId></ArticleIdList></Reference><Reference><Citation>Truant R, et al. Identification and functional characterization of a novel nuclear localization signal present in the yeast Nab2 poly(A)+ RNA binding protein. Mol Cell Biol. 1998;18(3):1449&#x2013;1458. doi: 10.1128/MCB.18.3.1449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.18.3.1449</ArticleId><ArticleId IdType="pmc">PMC108859</ArticleId><ArticleId IdType="pubmed">9488461</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, et al. A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci U S A. 2011;108(52):20881&#x2013;20890. doi: 10.1073/pnas.1109434108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109434108</ArticleId><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldschmidt L, et al. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci U S A. 2010;107(8):3487&#x2013;3492. doi: 10.1073/pnas.0915166107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0915166107</ArticleId><ArticleId IdType="pmc">PMC2840437</ArticleId><ArticleId IdType="pubmed">20133726</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson JS, Richardson DC. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci U S A. 2002;99(5):2754&#x2013;2759. doi: 10.1073/pnas.052706099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.052706099</ArticleId><ArticleId IdType="pmc">PMC122420</ArticleId><ArticleId IdType="pubmed">11880627</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J, Taylor JP. Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assembly. Rare Dis. 2013;1:e25200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932941</ArticleId><ArticleId IdType="pubmed">25002999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, et al. Gatekeeper residues in the major curlin subunit modulate bacterial amyloid fiber biogenesis. Proc Natl Acad Sci U S A. 2010;107(1):163&#x2013;168. doi: 10.1073/pnas.0908714107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908714107</ArticleId><ArticleId IdType="pmc">PMC2806774</ArticleId><ArticleId IdType="pubmed">19966296</ArticleId></ArticleIdList></Reference><Reference><Citation>Siomi H, Dreyfuss G. A nuclear localization domain in the hnRNP A1 protein. J Cell Biol. 1995;129(3):551&#x2013;560. doi: 10.1083/jcb.129.3.551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.129.3.551</ArticleId><ArticleId IdType="pmc">PMC2120450</ArticleId><ArticleId IdType="pubmed">7730395</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BJ, et al. Rules for nuclear localization sequence recognition by karyopherin beta 2. Cell. 2006;126(3):543&#x2013;558. doi: 10.1016/j.cell.2006.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.05.049</ArticleId><ArticleId IdType="pmc">PMC3442361</ArticleId><ArticleId IdType="pubmed">16901787</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, et al. Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol Cell. 2015;60(2):208&#x2013;219. doi: 10.1016/j.molcel.2015.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.08.018</ArticleId><ArticleId IdType="pmc">PMC4609299</ArticleId><ArticleId IdType="pubmed">26412307</ArticleId></ArticleIdList></Reference><Reference><Citation>Allemand E, et al. Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock. Proc Natl Acad Sci U S A. 2005;102(10):3605&#x2013;3610. doi: 10.1073/pnas.0409889102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0409889102</ArticleId><ArticleId IdType="pmc">PMC553333</ArticleId><ArticleId IdType="pubmed">15738418</ArticleId></ArticleIdList></Reference><Reference><Citation>Cammas A, et al. Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation of specific mRNAs. Mol Biol Cell. 2007;18(12):5048&#x2013;5059. doi: 10.1091/mbc.e07-06-0603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e07-06-0603</ArticleId><ArticleId IdType="pmc">PMC2096577</ArticleId><ArticleId IdType="pubmed">17898077</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael WM, et al. A nuclear export signal in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein export pathway. Cell. 1995;83(3):415&#x2013;422. doi: 10.1016/0092-8674(95)90119-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90119-1</ArticleId><ArticleId IdType="pubmed">8521471</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P, et al. G3BP1 is a tunable switch that triggers phase separation to assemble stress granules. Cell. 2020;181(2):325&#x2013;345. doi: 10.1016/j.cell.2020.03.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.046</ArticleId><ArticleId IdType="pmc">PMC7448383</ArticleId><ArticleId IdType="pubmed">32302571</ArticleId></ArticleIdList></Reference><Reference><Citation>Banfi S, et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet. 1994;7(4):513&#x2013;520. doi: 10.1038/ng0894-513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0894-513</ArticleId><ArticleId IdType="pubmed">7951322</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21(13):2899&#x2013;2911. doi: 10.1093/hmg/dds116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds116</ArticleId><ArticleId IdType="pmc">PMC3373238</ArticleId><ArticleId IdType="pubmed">22454397</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulst SM, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996;14(3):269&#x2013;276. doi: 10.1038/ng1196-269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1196-269</ArticleId><ArticleId IdType="pubmed">8896555</ArticleId></ArticleIdList></Reference><Reference><Citation>March ZM, et al. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Res. 2016;1647:9&#x2013;18. doi: 10.1016/j.brainres.2016.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.02.037</ArticleId><ArticleId IdType="pmc">PMC5003744</ArticleId><ArticleId IdType="pubmed">26996412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeda A, et al. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. EMBO J. 1994;13(22):5483&#x2013;5495. doi: 10.1002/j.1460-2075.1994.tb06883.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1994.tb06883.x</ArticleId><ArticleId IdType="pmc">PMC395506</ArticleId><ArticleId IdType="pubmed">7957114</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu I, et al. A novel role for the proteasomal chaperone PSMD9 and hnRNPA1 in enhancing I&#x3ba;B&#x3b1; degradation and NF-&#x3ba;B activation &#x2014; functional relevance of predicted PDZ domain-motif interaction. FEBS J. 2014;281(11):2688&#x2013;2709. doi: 10.1111/febs.12814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12814</ArticleId><ArticleId IdType="pubmed">24720748</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, et al. Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell. 2018;173(3):677&#x2013;692. doi: 10.1016/j.cell.2018.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZC, Chook YM. Structural and energetic basis of ALS-causing mutations in the atypical proline-tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS) Proc Natl Acad Sci U S A. 2012;109(30):12017&#x2013;12021. doi: 10.1073/pnas.1207247109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1207247109</ArticleId><ArticleId IdType="pmc">PMC3409756</ArticleId><ArticleId IdType="pubmed">22778397</ArticleId></ArticleIdList></Reference><Reference><Citation> Marrone L, et al. P525L promotes the aggregation of FUS by altering its biochemical and biophysical properties.  https://sciencematters.io/articles/202004000008/info Updated May 12, 2020. Accessed June 10, 2021.</Citation></Reference><Reference><Citation>Kruger R, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson&#x2019;s disease. Nat Genet. 1998;18(2):106&#x2013;108. doi: 10.1038/ng0298-106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0298-106</ArticleId><ArticleId IdType="pubmed">9462735</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway KA, et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson&#x2019;s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A. 2000;97(2):571&#x2013;576. doi: 10.1073/pnas.97.2.571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.2.571</ArticleId><ArticleId IdType="pmc">PMC15371</ArticleId><ArticleId IdType="pubmed">10639120</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162(5):1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegmann S, et al. Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J. 2018;37(7):e98049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5881631</ArticleId><ArticleId IdType="pubmed">29472250</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaan NM, et al. Liquid-liquid phase separation induces pathogenic tau conformations in vitro. Nat Commun. 2020;11(1):2809. doi: 10.1038/s41467-020-16580-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16580-3</ArticleId><ArticleId IdType="pmc">PMC7272632</ArticleId><ArticleId IdType="pubmed">32499559</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui X, et al. Structural basis for reversible amyloids of hnRNPA1 elucidates their role in stress granule assembly. Nat Commun. 2019;10(1):2006. doi: 10.1038/s41467-019-09902-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09902-7</ArticleId><ArticleId IdType="pmc">PMC6494871</ArticleId><ArticleId IdType="pubmed">31043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, et al. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>doi: 10.1101/628222. Curnin C, et al. Machine learning-based detection of insertions and deletions in the human genome [preprint]. Posted on bioRxiv December 25, 2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/628222</ArticleId></ArticleIdList></Reference><Reference><Citation>doi: 10.1101/627661. Holt JM, et al. Identification of pathogenic structural variants in rare disease patients through genome sequencing [preprint]. Posted on bioRxiv May 15, 2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/627661</ArticleId></ArticleIdList></Reference><Reference><Citation>Fresard L, et al. Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts. Nat Med. 2019;25(6):911&#x2013;919. doi: 10.1038/s41591-019-0457-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0457-8</ArticleId><ArticleId IdType="pmc">PMC6634302</ArticleId><ArticleId IdType="pubmed">31160820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng L, et al. An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res. 2004;32(14):e115. doi: 10.1093/nar/gnh110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gnh110</ArticleId><ArticleId IdType="pmc">PMC514394</ArticleId><ArticleId IdType="pubmed">15304544</ArticleId></ArticleIdList></Reference><Reference><Citation>Guthrie C, Fink GR. Guide to yeast genetics and molecular biology. Methods Enzymol. 1991;194:1&#x2013;863.</Citation><ArticleIdList><ArticleId IdType="pubmed">2005781</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito H, et al. Transformation of intact yeast cells treated with alkali cations. J Bacteriol. 1983;153(1):163&#x2013;168. doi: 10.1128/jb.153.1.163-168.1983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jb.153.1.163-168.1983</ArticleId><ArticleId IdType="pmc">PMC217353</ArticleId><ArticleId IdType="pubmed">6336730</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, et al. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol. 2011;9(4):e1000614. doi: 10.1371/journal.pbio.1000614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, et al. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem. 2009;284(30):20329&#x2013;20339. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>